These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 16143138

  • 1. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
    Howlett M, Judd LM, Jenkins B, La Gruta NL, Grail D, Ernst M, Giraud AS.
    Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
    [Abstract] [Full Text] [Related]

  • 2. The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development.
    Howlett M, Giraud AS, Lescesen H, Jackson CB, Kalantzis A, Van Driel IR, Robb L, Van der Hoek M, Ernst M, Minamoto T, Boussioutas A, Oshima H, Oshima M, Judd LM.
    Gastroenterology; 2009 Mar; 136(3):967-77. PubMed ID: 19121317
    [Abstract] [Full Text] [Related]

  • 3. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis.
    Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M, Giraud AS.
    Gastroenterology; 2006 Oct; 131(4):1073-85. PubMed ID: 17030178
    [Abstract] [Full Text] [Related]

  • 4. Cytokine signalling by gp130 regulates gastric mucosal healing after ulceration and, indirectly, antral tumour progression.
    Judd LM, Ulaganathan M, Howlett M, Giraud AS.
    J Pathol; 2009 Mar; 217(4):552-62. PubMed ID: 19097069
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
    Selander KS, Li L, Watson L, Merrell M, Dahmen H, Heinrich PC, Müller-Newen G, Harris KW.
    Cancer Res; 2004 Oct 01; 64(19):6924-33. PubMed ID: 15466183
    [Abstract] [Full Text] [Related]

  • 6. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F, Aono H, Ishihara K, Huseby E, Betz UA, Murakami M, Hirano T.
    Int Immunol; 2007 Jun 01; 19(6):695-702. PubMed ID: 17493959
    [Abstract] [Full Text] [Related]

  • 7. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, Asch BB, Baumann H.
    Oncogene; 2002 Sep 12; 21(41):6264-77. PubMed ID: 12214267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Construction of membrane-anchored interleukin-6 receptor beta subunit mutant and its effect on IL-6 signal transduction].
    Yang Z, Ni C, Shen B, Wang J, Wang Z.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec 12; 21(12):632-5. PubMed ID: 11877037
    [Abstract] [Full Text] [Related]

  • 10. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130.
    Judd LM, Alderman BM, Howlett M, Shulkes A, Dow C, Moverley J, Grail D, Jenkins BJ, Ernst M, Giraud AS.
    Gastroenterology; 2004 Jan 12; 126(1):196-207. PubMed ID: 14699500
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
    Streetz KL, Tacke F, Leifeld L, Wüstefeld T, Graw A, Klein C, Kamino K, Spengler U, Kreipe H, Kubicka S, Müller W, Manns MP, Trautwein C.
    Hepatology; 2003 Jul 12; 38(1):218-29. PubMed ID: 12830005
    [Abstract] [Full Text] [Related]

  • 13. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D, Ishihara K, Hirano T.
    Rev Physiol Biochem Pharmacol; 2003 Jul 12; 149():1-38. PubMed ID: 12687404
    [Abstract] [Full Text] [Related]

  • 14. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA, Brailly H, Sautès C, Joyeux I, Dorval T, Mosseri V, Yasukawa K, Wijdenes J, Adler A, Gorin I, Fridman WH, Tartour E.
    Clin Cancer Res; 1997 Aug 12; 3(8):1443-51. PubMed ID: 9815830
    [Abstract] [Full Text] [Related]

  • 15. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.
    Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T.
    EMBO J; 1996 Apr 01; 15(7):1557-65. PubMed ID: 8612579
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.
    Sawa S, Kamimura D, Jin GH, Morikawa H, Kamon H, Nishihara M, Ishihara K, Murakami M, Hirano T.
    J Exp Med; 2006 Jun 12; 203(6):1459-70. PubMed ID: 16717113
    [Abstract] [Full Text] [Related]

  • 19. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
    Klein C, Wüstefeld T, Assmus U, Roskams T, Rose-John S, Müller M, Manns MP, Ernst M, Trautwein C.
    J Clin Invest; 2005 Apr 12; 115(4):860-9. PubMed ID: 15761498
    [Abstract] [Full Text] [Related]

  • 20. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M, Richards CD, Gauldie J.
    Cytokine; 1995 Aug 12; 7(6):503-9. PubMed ID: 8580365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.